Norway
· Delayed Price · Currency is NOK Nordhealth AS Statistics
Total Valuation
Nordhealth AS has a market cap or net worth of NOK 2.93 billion. The enterprise value is 2.69 billion.
| Market Cap | 2.93B |
| Enterprise Value | 2.69B |
Important Dates
The next estimated earnings date is Tuesday, November 12, 2024.
| Earnings Date | Nov 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Nordhealth AS has 79.07 million shares outstanding. The number of shares has decreased by -1.21% in one year.
| Shares Outstanding | 79.07M |
| Shares Change (YoY) | -1.21% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 50.31% |
| Owned by Institutions (%) | 20.43% |
| Float | 37.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.20 |
| PB Ratio | 3.27 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -25.26 |
| EV / Sales | 5.71 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -31.63 |
Financial Position
The company has a current ratio of 2.77
| Current Ratio | 2.77 |
| Quick Ratio | 2.65 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -540.39 |
Financial Efficiency
Return on equity (ROE) is -11.16% and return on invested capital (ROIC) is -7.27%.
| Return on Equity (ROE) | -11.16% |
| Return on Assets (ROA) | -6.37% |
| Return on Capital (ROIC) | -7.27% |
| Revenue Per Employee | 1.19M |
| Profits Per Employee | -269,870 |
| Employee Count | 395 |
| Asset Turnover | 0.43 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +53.53% in the last 52 weeks. The beta is 0.51, so Nordhealth AS's price volatility has been lower than the market average.
| Beta (5Y) | 0.51 |
| 52-Week Price Change | +53.53% |
| 50-Day Moving Average | 34.01 |
| 200-Day Moving Average | 29.01 |
| Relative Strength Index (RSI) | 54.93 |
| Average Volume (20 Days) | 23,334 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Nordhealth AS had revenue of NOK 471.77 million and -106.60 million in losses. Loss per share was -1.35.
| Revenue | 471.77M |
| Gross Profit | 139.40M |
| Operating Income | -111.06M |
| Pretax Income | -103.81M |
| Net Income | -106.60M |
| EBITDA | -47.02M |
| EBIT | -111.06M |
| Loss Per Share | -1.35 |
Balance Sheet
| Cash & Cash Equivalents | 232.70M |
| Total Debt | n/a |
| Net Cash | 232.70M |
| Net Cash Per Share | 2.94 |
| Equity (Book Value) | 894.37M |
| Book Value Per Share | 11.31 |
| Working Capital | 210.37M |
Cash Flow
In the last 12 months, operating cash flow was -24.97 million and capital expenditures -60.16 million, giving a free cash flow of -85.13 million.
| Operating Cash Flow | -24.97M |
| Capital Expenditures | -60.16M |
| Free Cash Flow | -85.13M |
| FCF Per Share | -1.08 |
Margins
Gross margin is 29.55%, with operating and profit margins of -23.54% and -22.60%.
| Gross Margin | 29.55% |
| Operating Margin | -23.54% |
| Pretax Margin | -22.00% |
| Profit Margin | -22.60% |
| EBITDA Margin | -9.97% |
| EBIT Margin | -23.54% |
| FCF Margin | -18.05% |
Dividends & Yields
Nordhealth AS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.21% |
| Shareholder Yield | 1.21% |
| Earnings Yield | -3.64% |
| FCF Yield | -2.91% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |